# Validation of the In-utero Transmission of Probiotics

> **NCT04050189** · PHASE2 · COMPLETED · sponsor: **Centre de recherche du Centre hospitalier universitaire de Sherbrooke** · enrollment: 52 (actual)

## Conditions studied

- In Utero Drug Exposure

## Interventions

- **BIOLOGICAL:** Natural products: Probiotics
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04050189
- **Lead sponsor:** Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-27
- **Primary completion:** 2023-08-28
- **Final completion:** 2023-11-28
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04050189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04050189, "Validation of the In-utero Transmission of Probiotics". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04050189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*